Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 151.16B P/E 22.74 EPS this Y 3.30% Ern Qtrly Grth 13.70%
Income 6.83B Forward P/E 15.27 EPS next Y 5.30% 50D Avg Chg 8.00%
Sales 26.33B PEG 2.31 EPS past 5Y 7.25% 200D Avg Chg 15.00%
Dividend 3.00% Price/Book 41.37 EPS next 5Y 7.00% 52W High Chg -5.00%
Recommedations 2.80 Quick Ratio 1.17 Shares Outstanding 533.58M 52W Low Chg 37.00%
Insider Own 0.21% ROA 9.93% Shares Float 532.49M Beta 0.65
Inst Own 79.00% ROE 115.16% Shares Shorted/Prior 10.43M/16.84M Price 283.29
Gross Margin 75.78% Profit Margin 25.96% Avg. Volume 2,844,171 Target Price 262.60
Oper. Margin 38.82% Earnings Date Feb 6 Volume 2,487,444 Change -0.57%
Amgen Inc. News
01:42 AM UPDATE 1-Mirati to focus adagrasib/Keytruda study in low PDL1 lung cancer patients
12/05/22 Horizon Topples After J&J Pulls Out Of Bidding War, Leaving Amgen, Sanofi
12/03/22 Amgen says experimental obesity drug has promising durability
12/02/22 Amgen (NASDAQ:AMGN) shareholders have earned a 14% CAGR over the last five years
12/02/22 Is Amgen Stock a Buy for Income Investors?
12/01/22 Amgen Is The Underdog In Obesity Treatment — But It's Creeping Up On Novo Nordisk, Eli Lilly
12/01/22 AMGEN PRESENTS NEW AMG 133 PHASE 1 CLINICAL DATA AT WCIRDC 2022
11/30/22 Horizon Therapeutics Rockets As It Considers Potential Bids From Amgen, J&J, Sanofi
11/30/22 Analyst Forecasts $101-117/Share Offer Price For Horizon Therapeutics' Buyout
11/30/22 Horizon Therapeutics in Separate Sale Talks With Amgen, Sanofi, J&J
11/30/22 Why Horizon Therapeutics Stock Is Skyrocketing Today
11/30/22 UPDATE 3-J&J sues Amgen over plan to sell drug similar to blockbuster Stelara
11/30/22 J&J sues Amgen over plan to sell drug similar to blockbuster Stelara
11/29/22 Horizon Therapeutics Fields Takeover Interest From Pharma Giants
11/28/22 AMGEN TO WEBCAST INVESTOR CALL AT WCIRDC 2022
11/28/22 With Amgen Inc. (NASDAQ:AMGN) It Looks Like You'll Get What You Pay For
11/24/22 Possible bearish signals as Amgen Inc. (NASDAQ:AMGN) insiders disposed of US$5.2m worth of stock
11/23/22 AMGEN ANNOUNCES WEBCAST OF 2022 EVERCORE ISI HEALTHCARE CONFERENCE
11/21/22 Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

AMGN Chatroom

User Image cctranscripts Posted - 7 hours ago

Check out notes offered up on the $AMGN earnings call transcript https://conferencecalltranscripts.com/summary/?id=465953&pr=true

User Image STCKPRO Posted - 8 hours ago

$AMGN NEW ARTICLE : Mirati Therapeutics Crashes As The Cancer Rivalry With Amgen Heats Up https://www.stck.pro/news/AMGN/38586719

User Image stocktargetadvisors Posted - 8 hours ago

$AMGN latest rating from Oppenheimer Holdings on 2022-12-06, setting target price at: USD 310.00 with a rating of . The average analyst target price isUSD 252.45. StockTargetAdvisor's own view is Slightly Bullish . Details: https://www.stocktargetadvisor.com/stock/USA/NSD/AMGN

User Image Daniel_Adam Posted - 9 hours ago

$HZNP with $JNJ out a $27.5 bln cash offer represents 18.1% of $AMGN mkt cap and 24% of $SNY total mkt cap with a recession looming (imo we are already in one) and I am not buying into a soft landing it’s really foolish to be making cash only deals in this geopolitical, macro economic environment

User Image Newsfilter Posted - 9 hours ago

$AMGN Oppenheimer analyst Jay Olson maintains Amgen with a Outperform and raises the price target from $300 to $310.

User Image MarketBeat Posted - 11 hours ago

Amgen's PT raised by Oppenheimer Holdings Inc. to $310.00. https://www.marketbeat.com/r/1860429 $AMGN

User Image macroaxis Posted - 11 hours ago

$AMGN - Is sell-off trend sliding https://www.macroaxis.com/volatility/AMGN/Amgen-Inc #stocks #earnings

User Image Newsfilter Posted - 13 hours ago

$AMGN Approval of Blincyto, Bla #125557 https://newsfilter.io/a/f410b9e4b9d194bd46b8f92c2f1c324c

User Image FirstDayTrader Posted - 19 hours ago

Top Flow for Monday 🔔: $AMGN with a single CALL Trade for total premium worth $99.3K Ranking #261 Monday | This was a SWEEP trade. | Platform is SweepCast.com 🗝️

User Image Dr_Stoxx Posted - 1 day ago

It's always a good idea to mark what stocks are up on a deep red market day. I just ran my "A-List" scanner in @MarketSmith and here are the top 3 stocks sorted by Price % Change: $PDD $AON $AMGN. Keep an eye on these guys. #IBDPartner @InvestorsBusinessDaily

User Image MarketBeat Posted - 1 day ago

Amgen's PT raised by Piper Sandler to $297.00. https://www.marketbeat.com/r/1860222 $AMGN

User Image STCKPRO Posted - 1 day ago

$AMGN NEW ARTICLE : Amgen Inc. (AMGN) World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease Conference (Transcript) https://www.stck.pro/news/AMGN/38536278

User Image stockilluminati Posted - 1 day ago

$AMGN https://www.stockilluminati.com/amgn/news.php - AMGN WCIRDC_Conference_Slides

User Image stockilluminati Posted - 1 day ago

$AMGN https://www.stockilluminati.com/amgn/news.php - Amgen Inc. (AMGN) World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease Conference (Transcript)

User Image theflynews Posted - 1 day ago

Amgen price target raised to $297 from $278 at Piper Sandler - $AMGN - https://thefly.com/permalinks/entry.php/AMGNid3627734

User Image TraderIsaac Posted - 1 day ago

$AMGN On watch list. Has DTL & AVWAP to get above within 4 week tight flag.https://share.trendspider.com/chart/AMGN/8045azt5po

User Image Albino_Trader123 Posted - 1 day ago

$AMGN great pipeline. consolidating flsg nicely

User Image Daniel_Adam Posted - 1 day ago

$HZNP I think $JNJ dropping out is a sign $HZNP overvalued itself in preparation to be acquired if you consider the simple fact $JNJ has a market cap of $465 billion to $AMGN $152.3 billion and sanofi’s ~ $115 billion market cap it’s not an issue of having the capital to make the acquisition in cash I just think jnj doesn’t see the value in hznp’s asset to pay what whatever the asking price is

User Image STCKPRO Posted - 1 day ago

$AMGN NEW ARTICLE : Wall Street Analysts Are Neutral on Top Healthcare Picks https://www.stck.pro/news/AMGN/38529799

User Image STCKPRO Posted - 1 day ago

$AMGN NEW ARTICLE : Horizon Topples After J&J Pulls Out Of Bidding War, Leaving Amgen, Sanofi https://www.stck.pro/news/AMGN/38529332

User Image STCKPRO Posted - 1 day ago

$AMGN NEW ARTICLE : Analysts Offer Insights on Healthcare Companies: Vaxxinity Inc (VAXX), Amgen (AMGN) and LivaNova (LIVN) https://www.stck.pro/news/AMGN/38528279

User Image OpenOutcrier Posted - 1 day ago

$HZNP (-4.1% pre) J&J $JNJ opts out of Horizon leaving out Amgen $AMGN, Sanofi $SNY as only bidders - SA http://ooc.bz/l/114438

User Image STCKPRO Posted - 1 day ago

$AMGN NEW ARTICLE : Which Is Faster: Caterpillar Or Deere? https://www.stck.pro/news/AMGN/38525979

User Image STCKPRO Posted - 1 day ago

$AMGN NEW ARTICLE : 7 Christmas Stocks to Buy for Happy Holidays https://www.stck.pro/news/AMGN/38524295

User Image STCKPRO Posted - 1 day ago

$AMGN NEW ARTICLE : Mizuho Securities Remains a Hold on Amgen (AMGN) https://www.stck.pro/news/AMGN/38507883

User Image macroaxis Posted - 2 days ago

Build optimal portfolios with Amgen( $AMGN ), Goldman… https://www.macroaxis.com/invest/stock-volatility?s=AMGN,GS,CSCO,LIFE,EW,EA,INTC,HES,CVS,STBA,MUR #insidertrading #stocks #fintechnews

User Image STCKPRO Posted - 2 days ago

$AMGN NEW ARTICLE : Dow Stocks To Trade In December https://www.stck.pro/news/AMGN/38497779

User Image UltraAlgo Posted - 2 days ago

UltraAlgo | $AMGN Bullish pattern based off 9 signals on the 15-min chart. #AMGN https://pbs.twimg.com/media/Fi5YD4aXgAQcLqg.jpg

User Image suriNotes Posted - 2 days ago

$AMGN Bull Flag Pattern + Rev. Spiral

User Image macroaxis Posted - 2 days ago

New volatility landscape for Amgen( $AMGN ), ATT( $T ),… https://www.macroaxis.com/invest/stock-volatility?s=AMGN,T,HSY,IFF,NWSA,KEY,ABC,EQT,USB,DINO,TJX,HOMB #correlations #stocks #stockratings

Analyst Ratings
Credit Suisse Underperform Nov 18, 22
RBC Capital Sector Perform Nov 4, 22
Morgan Stanley Overweight Nov 4, 22
Piper Sandler Overweight Nov 4, 22
Barclays Underweight Oct 31, 22
Barclays Equal-Weight Oct 12, 22
Morgan Stanley Overweight Oct 11, 22
Atlantic Equities Underweight Aug 9, 22
RBC Capital Sector Perform Aug 5, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Khosla Rachna SVP, Business Develo.. SVP, Business Development Nov 09 Sell 292.90 387 113,352 6,630 11/10/22
Grygiel Nancy A. SVP & CCO SVP & CCO Nov 05 Sell 293.54 545 159,979 13,009 11/08/22
Williams R Sanders Director Director Aug 22 Sell 249.96 200 49,992 5,301 08/22/22
ECKERT ROBERT Director Director Aug 18 Sell 248.9966 6,600 1,643,378 21,184 08/19/22
ECKERT ROBERT Director Director Aug 10 Option 85.59 20,000 1,711,800 34,575 08/12/22
Williams R Sanders Director Director May 23 Sell 250.00 600 150,000 5,501 05/23/22
Graham Jonathan P EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secy. May 10 Sell 241.8114 13,500 3,264,454 37,333 05/10/22
SUGAR RONALD D Director Director May 12 Option 71.64 1,000 71,640 16,927 05/12/21
SUGAR RONALD D Director Director May 12 Sell 250.59 1,000 250,590 15,927 05/12/21
Grygiel Nancy A. SVP & CCO SVP & CCO May 12 Sell 252.51 2,500 631,275 12,461 05/12/21
Grygiel Nancy A. SVP & CCO SVP & CCO May 12 Option 162.6 2,500 406,500 14,961 05/12/21
SUGAR RONALD D Director Director Apr 15 Option 71.64 1,000 71,640 16,927 04/15/21
SUGAR RONALD D Director Director Apr 15 Sell 249.98 1,000 249,980 15,927 04/15/21
SUGAR RONALD D Director Director Mar 10 Option 71.64 1,000 71,640 16,805 03/10/21
SUGAR RONALD D Director Director Mar 10 Sell 231.53 1,000 231,530 15,805 03/10/21
Bradway Robert A Chairman, CEO and Pr.. Chairman, CEO and President Feb 22 Option 54.69 73,500 4,019,715 618,380 02/22/21
REESE DAVID M EVP, Research and De.. EVP, Research and Development Feb 16 Option 54.69 2,300 125,787 42,059 02/16/21
SUGAR RONALD D Director Director Feb 10 Option 71.64 1,000 71,640 16,805 02/10/21
SUGAR RONALD D Director Director Feb 10 Sell 238.4 1,000 238,400 15,805 02/10/21
SUGAR RONALD D Director Director Jan 14 Option 71.64 1,000 71,640 16,805 01/14/21
SUGAR RONALD D Director Director Jan 14 Sell 235.99 1,000 235,990 15,805 01/14/21